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Abstract 
This study was carried out to investigate the renoprotective effect of Portulaca oleracea on cisplatin-induced 
nephrotoxic wistar rats. Twenty four (24) female wistar rats were randomly divided into six (6) groups - Group 
A were given no treatment and served as the control group; Group B was given only a single dose of cisplatin 
(2ml/kg) and served as the cisplatin control group. Groups C and D were orally given 400mg/kg and 800mg/kg 
body weight of methanolic extract of portulaca oleracea (MEPO) respectively 6 hours after cisplatin injection 
(2ml/kg) . Groups E and F were orally given 400mg/kg and 800mg/kg body weight of MEPO respectively 
6hours before cisplatin injection (2ml/kg) for 7 days. The effect of the treatment on relative kidney weight, 
serum creatinine level, serum uric acid and histoarchitecture of the rat kidney were accessed. Results showed 
significantly decreased serum creatinine levels (p<0.05) in rats treated with 400mg/kg b.wt. and 800mg/kg b.wt.  
MEPO as compared with the cisplatin control group. Serum uric acid was significantly decreased  in groups C, 
D, E, and F when compared with control A. The relative average weight of the kidney increased significantly in 
all treated groups except group treated with 800mg/kg b.wt. MEPO 6hours before cisplatin. Kidney histological 
slides showed both recovery from and prevention of effects of induced toxicity at all treatment doses. Results 
suggest that Portulaca oleracea extract may be used to cure or prevent cisplatin-induced renal toxicity without 
any adverse effect; hence it can serve as a novel combination agent with cisplatin to limit renal injury. 
Keywords: Cisplatin, portulaca oleracea, renoprotection, nephrotoxicity. 
 
INTRODUCTION 
Plant-based drugs have been used against various diseases for a long period of time. The primitive man used 
herbs as therapeutic agents and medicament, which they were able to procure easily[3]. 
Portulaca oleracea L.  belongs to the family of Portulacaceae. It is commonly called Purslane in English 
language, babbajibji in Hausa language and esan omode or papasan in Yoruba language[5]; however it is called 
ntioke, ntilimoke, ntiike,or  idiridi in Igbo language[21]. It has been reported to be rich in α-linolenic acid and β-
carotene and a healthy food for patients with cardiovascular diseases[14].  It is used in the Arabian peninsula as 
antiseptic, anti-scorbutic, and antispasmodic[7]; In China, it is used as an anti-bacterial and anti-viral agent, and 
for the treatment of viral hepatitis and in diabetes management[11].  
The kidneys are a primary component of the body’s defense against toxins and other foreign substances in the 
environment. Despite the importance of the excretion of metabolic waste products and potential toxins, the threat 
to life in renal failure typically comes not from the accumulation of metabolic wastes or environmental toxins, 
but from the loss of the body’s ability to balance the daily intake of salts and water by an appropriate rate of 
excretion[12].  
Nephrotoxicity is a poisonous effect of some substances, both toxic chemicals and medication, on the kidneys. 
Drugs are a common source of acute kidney injury. Compared with 30 years ago, the average patient today is 
older, has more comorbidity, and is exposed to more diagnostic and therapeutic procedures with the potential to 
harm kidney function[10]. Drugs shown to cause nephrotoxicity exert their toxic effects by one or more common 
pathogenic mechanisms. Drug-induced nephrotoxicity tends to be more common among certain patients and in 
specific clinical situations[13]. The essential values of some plants have long been published; however a number 
of them remain unexplored yet, therefore there is a necessity to explore their uses and to conduct 
pharmacognostic and pharmacological studies to ascertain their therapeutic properties[3]. 
 
MATERIAL AND METHOD 
LOCATION AND DURATION: This study was conducted in the Department of Anatomy, College of Health 
Sciences, Nnamdi Azikiwe University Nnewi campus and lasted for about three months. 
PLANT COLLECTION: fresh aerial parts of Portulaca Oleracea plant was harvested from the surroundings of 
Nnamdi Azikiwe University Awka and authenticated by Department of Pharmacognosy and Traditional 
Medicine, College of Pharmacy, Nnamdi Azikiwe University, Agulu Campus with reference number PCG477. 
The plant was washed, cut into smaller parts (for easy drying), shade-dried for two weeks and finely powdered 
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with a mechanical grinder yielding 550g of powder. 
PREPARATION OF EXTRACT OF PLANT: a methanolic extract of the powdered portulaca oleracea (430g) 
was prepared using soxhlet apparatus and the extract (1L) concentrated using a rotary evaporator at reduced 
pressure of 40°C yielding 69.79g dry extract. The extract was made up to solution at varying doses per ml on 
each day of administration and given according to body weight and groups. 
DRUGS/CHEMICAL: Cisplatin drug was obtained from Christ the king pharmarcy, Nnewi and was certified by 
Faculty of pharmacy, Nnamdi Azikiwe University, Agulu Campus 
ETHICAL APPROVAL: Ethical approval was gotten from the ethical committee of the faculty of Basic Medical 
Sciences College of Health Sciences, Nnamdi Azikiwe University Nnewi Campus for animal based research. 
ANIMALS: Twenty four (24) female wistar rats were obtained from the animal house of College of Health 
Sciences, Nnamdi Azikiwe University, Okofia Nnewi Campus and acclimatized for two (2) weeks (to exclude 
any intercurrent infection) under standard housing condition (ventilated room with 12/12 hour light/dark cycle at 
24 ± 20C). The rats were fed ad libitum with water and standard rat chow. The experiment was conducted in 
accordance with the guiding principles in the use of animals in toxicology, adopted by the society of toxicology 
in July 1989.  
EXPERIMENTAL DESIGN: The rats were randomly divided into six (6) groups (A-F) irrespective of their 
varying weight. Group A were given no treatment and served as control group for the experiment. Group B was 
given only a single dose of cisplatin (2ml/kg); it serves as cisplatin control group. Group C was given 400mg/kg 
of body weight of Methanolic extract of portulaca oleracea (MEPO) 6hours after a single dose cisplatin injection 
(2ml/kg). Group D was administered 800mg/kg of body weight of MEPO 6 hours after cisplatin injection 
(2ml/kg). Group E was administered 400mg/kg body weight of MEPO 6 hours before cisplatin injection. Group 
F was administered 800mg/kg body weight of MEPO 6 hours before cisplatin injection. MEPO extract 
administration was by oral route via an oral cannula. Cisplatin drug was administered intraperitonially. The daily 
dose for all administration was given for 7 days. The animals were fasted overnight after the 7th day of drug 
administration and on the 8th day, 5ml blood sample was collected by cardiac puncture into centrifuge tubes. The 
serum was separated by allowing blood sample for 15 minutes at 25oC then centrifuged at 4000rpm for 20 
minutes, then kept in plastic vials at -20oC until analysis. After blood collection , the animal were euthanized 
under diethyl ether anaesthesia and their kidney excised, rinsed in cold saline and fixed in 10% formal saline 
prior to histological processing. 
BIOCHEMICAL ASSAY: Serum creatinine levels were measured using the JAFF’S method as modified by 
Ochei and Kolhatka, 2000[19]. Serum Uric acid of the rats was also observed. 
TISSUE PROCESSING: For easy study of sections under microscope the tissues were trimmed down to a size of 
about 3mm x 3mm thick and fixed in 10% formaldehyde. After fixation, dehydration of the fixed tissues was 
done in ascending grades of alcohol 50%, 70% and 95% absolute and cleared in xylene. Staining was done with 
heamatoxylene and eosin and mounted using DPX. After which, the sections were viewed under the light 
microscope. Photomicrographs of these sections were obtained using the digital photomicroscope . 
STATISTICAL ANALYSIS: Data generated were analyzed using the SPSS software (v. 16.0). The results were 
expressed as mean value ± SD. Differences between mean and the main effects of treatment group were 
determined by the one way analysis of variance (ANOVA).  P<0.05 was considered significant. 
 
RESULTS                                                                                                                                                                               
Table 1.0 relative kidney weight of rats after drug administration (mean±S.D) 
Table 1.0 shows the relative kidney weight after drug administration. Group B showed significant decrease in 
kidney weight when compared with groups A, C, D, and E. (p<0.05). Group F rats had a significantly lower 
kidney weight than group A, C and D (p<0.05). 
 
GROUPS RELATIVE KIDNEY WEIGHT ( grams) 
CONTROL 0.7950±0.02082 
CISPLATIN ONLY 0.6150±0.07141 
400MG MEPO AFTER CISPLATIN 0.7900±0.07483 
800MG MEPO AFTER CISPLATIN 0.8775±0.06185 
400MG MEPO BEFORE CISPLATIN 0.7300±0.07165 
800MG MEPO BEFORE CISPLATIN 0.6475±0.04272 
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Table 2.0 kidney analyte concentrations of treated groups (mean±S.D) 
GROUPS SERUM CREATININE ( mg/dl) SERUM URIC ACID ( mg/dl) 
CONTROL 0.2067±0.00577 2.4700±0.01732 
CISPLATIN ONLY 0.6100±0.00000 2.0300±0.01732 
400MG MEPO AFTER CISPLATIN 0.3850±0.03536 1.7000±0.01732 
800MG MEPO AFTER CISPLATIN 0.2400±0.00000 1.9633±0.02517 
400MG MEPO BEFORE CISPLATIN 0.2867±0.00577 1.8600±0.01732 
800MG MEPO BEFORE CISPLATIN 0.0667±0.01155 2.1033±0.36116 
 
Table 2.0 shows the serum creatinine and uric acid concentrations of various groups. Group B showed a 
significantly higher serum creatinine when compared to all the other groups (p<0.05). The control group showed 
a significantly lower than all treated groups except group F which was significantly lower than all the groups 
including the control group (p<0.05). the serum uric acid showed a significant decrease in group B when 
compared to group A. group C, D, E, and F showed a significant decrease in serum uric acid when compared 
with group A while group C showed a significant decrease with group B. 
Table 3.0 histological features observed in the kidney tissues from the various groups 
GROUPS TUBULAR 
NECROSIS AND 
DISRUPTION 
PELVIS NECROSIS 
AND 
HAEMORRHAGE 
INFLAMMATORY 
CELLULAR 
INFILTRATION 
HYPOPERFUSED 
GLOMERULI 
CONTROL - - - - 
CISPLATIN 
ONLY 
+++ +++ ++ - 
400MG MEPO 
AFTER 
CISPLATIN 
+ - + - 
800MG MEPO 
AFTER 
CISPLATIN 
+ - - - 
400MG MEPO 
BEFORE 
CISPLATIN 
+ - - - 
800MG MEPO 
BEFORE 
CISPLATIN 
 
- - - - 
KEY 
- Absence 
+ Mild 
++ Moderate 
+++ Severe 
 
TABLE 3.0 shows the grading of the observed histological features of the kidney tissues of various groups. 
Group A showed normal kidney histological architecture. Group B showed severe pelvis and tubular necrosis 
with pelvis and tubular disruptions and haemmorhage. It further showed a moderate inflammatory cellular 
infiltration. Group C showed a mild tubular necrosis with pelvis inflammation; however this group showed no 
pelvis necrosis, haemmorhage or hypoperfused glomeruli. Groups D and E showed a normal kidney histological 
architecture except with a mid tubular necrosis and disruption while group F showed a complete normal tissue 
histological architecture without any tissue pathology. 
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DISCUSSION 
This study investigated the possible renoprotective effect of orally administered methanolic extract of portulaca 
oleracea on cisplatin induced nephrotoxicity in wistar rats. The study was designed to ascertain the nature of this 
effect, whether curative or preventive, the dose-relationship effect and the effect of portulaca oleracea on relative 
kidney weight. 
Cisplatin is the most common antitumor drug in clinic hence its use in this research work with nephrotoxicity as 
its most common side effect. Nephrotoxicity of the drug is usually associated with their accumulation in renal 
cortex, dependent upon their affinity to kidney and on kinetics of drug trapping process[2]. it is a platinum 
compound which is accompanied by decrease in glomerular filteration rate, increase in blood urea nitrogen, 
serum levels of creatinine and tubular injury. Cisplatin is known to accumulate in mitochondria of renal 
epithelial cells and induces ROS primarily by decreasing the activity of antioxidant enzymes and by depleting 
intracellular concentrations of GSH and also causes peroxidation of membrane lipids[18,24,26]. The cytotoxic 
action of the drug is often thought to be associated with its ability to bind DNA adducts[32]. Cisplatin induced 
oxidative stress can activate some protein kinases which sensitize the injured cell to apoptosis[9]. At the dose of 
2ml/kg, cisplatin was able to cause a significant nephrotoxicity as evidenced by the increased serum creatinine 
(p<0.05) in the cisplatin control group (table 2.0). This group showed a mean value of 0.6100mg/dl of creatinine 
as compared with 0.2067mg/dl of the normal control group. There was also a significant decrease of serum uric 
acid in cisplatin group as compared with the control. The decrease in uric acid as a result of cisplatin 
administration contradicts the finding of Paoulomi et al, 2012[25] that saw no significant effect of cisplatin 
administration with uric acid. 
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The daily intraperitonial administration of 2ml/kg cisplatin showed significant decrease (p>0.05) in kidney 
weight as compared with the control group (tables 1.0)  
The histological features of the kidney tissues of rats treated with cisplatin showed extensive pelvis 
haemmorhage, tubular necrosis and mild disruption when compared with the control group (table 3.0; plates I-
V). 
Portulaca oleracea (PO) ranked as the eight most common plant in the world[20],  and described as a ‘power food’ 
of the future[29] has a long history of use as human and animal food and in medicine hence its use in this 
research. Preliminary quantitative and qualitative phytochemical analysis carried out on portulaca oleracea 
extract showed its high content of saponin (32%) followed by alkaloid (26%)  amongst other bioactive 
compounds observed[22]   
Methanolic extract of portulaca oleracea (MEPO) was administered in varying doses 6hours before or after 
2ml/kg cisplatin injection with regards to its lethal dose (LD50)[17]. This is to observe its attenuating effect on the 
damages caused by cisplatin drug. From this study, all doses of PO administered showed that there was 
significant decrease in serum creatinine level (p<0.05) in treated groups as compared to the cisplatin group. there 
was a significant decrease in serum uric acid in animals given cisplatin only (group B) when compared with the 
control group ( p<0.05) but groups C, D, E, and F showed a significant decrease when compared with group A. 
only group C was able to show a significant decrease in serum uric acid when compared with group B (p<0.05). 
this suggests the role of MEPO  in reducing serum uric acid level which was seen to be more in group C 
(p<0.05) ( table 2.0). Except in groups treated with 800mg/kg of MEPO 6hours before injection, all other treated 
groups showed significant increase in the average kidney weight (p<0.05) when compared with the group given 
cisplatin alone. The rapid cell growth ability of PO supports the presence of protein and starch already observed 
in its phytochemical analysis[22]. 
The histological findings from the rat kidney specimen showed that at all the treated groups, there was an 
effective renoprotection by different doses of MEPO when compared with the control and cisplatin group. 
However, there were mild necrosis, inflammation and disruptions noticed in tubules and pelvis of all the treated 
groups except in rats given 800mg/kg MEPO before cisplatin which showed essentially normal kidney histology 
when compared with the control and cisplatin group (plates I-XIII). PO showed a cell regenerative and an anti-
haemmorhoidal ability in the treated groups when compared with the kidney of rats given cisplatin injection only 
although this healing effect was seen to be dose related and time related as the group that took 800mg/kg MEPO 
before cisplatin injection showed complete recovery. 
The antioxidant property of PO has been proved[29] and its renoprotective ability could be due to this property. 
Flavonoid present in PO has been validated as antioxidant acting by free scavenging activity. Also present in PO 
in high quantity is saponin and alkaloid proved to be a surfactant and an analgesic respectively[27]. This suggests 
that the renoprotective effect of the MEPO may be due to single or combined effect of its bioactive substances. 
Other constituents of PO like omega-3, ascorbic acid, β-carotene and glutathione have antioxidant activity[6,23,28]. 
So this plant may inhibit lipid peroxidation by scavenging free radicals and increasing intracellular concentration 
of glutathione. The protection of the kidney tissues offered by PO against renal damage supports its already 
published anti-inflammatory effect[7,8,30]. 
Some antioxidant agents that have been used to ameloriate cisplatin-induced nephrotoxicity in rats include 
deferoxamine, methimazole,Vit. C, Vit. E, diethyl diothiocarbamate, L-histidinol, thyroquinone[1,4,15,16], but none 
of these have been proved to be clinically efficient to provide complete protection in patients without side 
effects. These natural antioxidants may offer comparatively safer alternatives to synthetic antioxidants which 
may cause serious or unacceptable adverse side effects[15]. 
The result of this research reveals that the MEPO had significant protective effect against cisplatin-induced 
nephrotoxicity and the effect was found to be in dose dependent manner. The animals treated with higher dose of 
MEPO (800mg/kg) both  6 hours before and after cisplatin showed higher protection with a higher significant 
decrease in serum creatinine level (p<0.05) and higher curative and preventive effect in the kidney tissues ( 
plates I-XIII). These findings agreed with Waala et al 2011[31] and Gholamreza et al 2010[9]. 
 
CONCLUSION 
Portulaca oleracea protects against acute cisplatin nephrotoxicity and may be considered as a potentially useful 
medicine for combination therapy with cisplatin. MEPO showed both curative and preventive potentials for 
nephrotoxicity in a dose dependent manner as 800mg/kg MEPO given both before and after showed better 
protection than the lower dose (400mg/kg). However, a total histological protection of the kidney tissue was seen 
to be in the group treated with 800mg/kg 6 hours before cisplatin injection suggesting that portulaca oleracea has 
a higher preventive effect than a curative one. Based on this study and other related researches, there is necessity 
for further research on the mechanism of action of PO as a renoprotective agent and to validate the claims of this 
study for a possible MEPO supplementation in cisplatin chemotherapy. 
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